Reducing Mortality in Cardiac Surgery With Levosimendan: A Meta-analysis of Randomized Controlled Trials

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 24, Issue 1, 2010, Pages 51-57

  Landoni, Giovanni ^a   Mizzi, Anna ^a   Biondi Zoccai, Giuseppe ^b   Bruno, Giovanna ^a   Bignami, Elena ^a   Corno, Laura ^a   Zambon, Massimo ^a   Gerli, Chiara ^a   Zangrillo, Alberto ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

cardiac anesthesia; cardiac biomarker; cardiac surgery; inotropic drug; levosimendan; meta analysis; mortality; troponin

Indexed keywords

LEVOSIMENDAN; TROPONIN;

ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFECT; HEART ATRIUM FIBRILLATION; HEART PROTECTION; HEART SURGERY; HUMAN; META ANALYSIS; OFF PUMP CORONARY SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL MORTALITY; SURVIVAL; SYSTEMATIC REVIEW;

CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS, OFF-PUMP; HEART DISEASES; HUMANS; HYDRAZONES; POSTOPERATIVE COMPLICATIONS; PYRIDAZINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 74449087114     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2009.05.031     Document Type: Article

References (29)

1. Chernov S.A. Early postoperative complications and prevention of them in ischemic heart disease patients after direct myocardial revascularization. Ter Arkh 74 (2002) 45-49
2. Thackray S., Eastaugh J., Freemantle N., et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure: A meta-regression analysis. Eur J Heart Fail 4 (2002) 515-529
3. Fellahi J.L., Parienti J.J., Hanouz J.L., et al. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: Propensity-adjusted analyses. Anesthesiology 108 (2008) 979-987
4. Toller W.G., and Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anestesiology 104 (2006) 556-569
5. Zangrillo A., Biondi-Zoccai G., Mizzi A., et al. Levosimendan reduces cardiac troponin release after cardiac surgery: A meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 23 (2009) 474-478
6. Alvarez J., Taboada M., Rodríguez J., et al. Hemodynamic effects of levosimendan following cardiac surgery. Rev Esp Anestesiol Reanim 52 (2005) 389-394
7. Alvarez J., Bouzada M., Fernández A.L., et al. Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev Esp Cardiol 59 (2006) 338-345
8. Järvelä K., Maaranen P., Sisto T., et al. Levosimendan in aortic valve surgery: Cardiac performance and recovery. J Cardiothoracic Vasc Anesth 22 (2008) 693-698
9. De Hert S.G., Lorsomradee S., vanden Eede H., et al. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction. J Cardiothoracic Vasc Anesth 22 (2008) 699-705
10. Levin R.L., Degrange M.A., Porcile R., et al. The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome. Rev Esp Cardiol 61 (2008) 471-479
11. Biondi-Zoccai G.G.L., Agostoni P., Abbate A., et al. A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials. Int J Epidemiol 34 (2005) 224-225
12. Higgins J.P.T., and Green S. The Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. http://www.cochrane.org/resources/handbook/hbook.htm Accessed October 10, 2005
13. Moher D., Cook D.J., Eastwood S., et al. Improving the quality of reports of meta-analyses of randomized controlled trials: The QUOROM Statement. Quality of reporting of meta-analyses. Lancet 354 (1999) 1896-1900
14. Biondi-Zoccai G.G., Lotrionte M., Abbate A., et al. Compliance with QUOROM and quality of reporting of overlapping meta-analysis on the role of acetylcysteine in the prevention of contrast associated nephropathy: Case study. BMJ 332 (2006) 202-209
15. Lilleberg J., Nieminem M.S., Akkila J., et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 19 (1998) 660-668
16. Jörgensen K., Bech-Hanssen O., Houltz E., et al. Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis. Circulation 117 (2008) 1075-1081
17. Tasouli A., Papadopoulos K., Antoniou T., et al. Efficacy and safety of perioperative levosimendan in patients with compromised cardiac function undergoing open-heart surgery: Importance of early use. Eur J Cardiothorac Surg 32 (2007) 629-633
18. Barisin S., Husedzinovic I., Sonicki Z., et al. Levosimendan in off-pump coronary artery bypass: A four-time masked controlled study. J Cardiovasc Pharmacol 44 (2004) 703-708
19. Husedžinović I., Barišin S., Bradić N., et al. Levosimendan as a new strategy during off-pump coronary artery bypass grafting: Double-blind randomized placebo-controlled trial. Croat Med J 46 (2005) 950-956
20. Al-Shawaf E., Ayed A., Vislocky I., et al. Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. J Cardiothorac Vasc Anesth 20 (2006) 353-357
21. Tritapepe L., De Santis V., Vitale D., et al. Preconditioning effects of levosimendan in coronary artery bypass grafting-A pilot study. Br J Anaesth 96 (2006) 694-700
22. De Hert S.G., Lorsomradee S., Cromheecke S., et al. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 104 (2007) 766-773
23. Kersten J.R., Montgomery M.W., Pagel P.S., et al. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 90 (2000) 5-11
24. du Toit E., Hofmann D., McCarthy J., et al. Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model. Heart 86 (2001) 81-87
25. Missant C., Rex S., Segers P., et al. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction. Crit Care Med 35 (2007) 707-715
26. Follath F., Cleland J.G., Just H., et al. Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial. Lancet 360 (2002) 196-202
27. Mebazaa A., Nieminen M.S., Packer M., et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE Randomized Trial. JAMA 297 (2007) 1883-1891
28. Cleland J.G., Freemantle N., Coletta A.P., et al. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail 8 (2006) 105-110
29. Biondi-Zoccai G.G., Agostoni P., and Abbate A. Parallel hierarchy of scientific studies in cardiovascular medicine. Ital Heart J 4 (2003) 819-820